Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat for erythropoietin-hyporesponsive anemia in long-term hemodialysis
ChiCTR1900028462Phase 4Completed
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of roxadustat in Uraemic Anaemia and anaemia, sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoint: Hemoglobin. Started Dec 2019; status: completed.
02
Drugs
roxadustat
03
Conditions
Uraemic Anaemiaanaemia
Beyond the preview
Go deeper on ChiCTR1900028462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028462.